U.S. has fostered quality of care through investment and achievements in medical science.

In less than a decade, the U.S. more than doubled NIH’s budget in nominal dollars—from about $11 billion in 1994 to over $23 billion in 2002.
The bulk of privately funded pharmaceutical research—over $25 billion—was conducted in the U.S.
Recent U.S. medical advances include mapping the human genome, treating the AIDS virus, and researching the use of vaccines for certain types of cancer.

In less than a decade, the U.S. more than doubled NIH’s budget in nominal dollars—from about $11 billion in 1994 to over $23 billion in 2002.